Debut
San Diego
About Debut
Debut Biotech develops biotechnology-based beauty ingredients and formulations in a vertically integrated manner, beginning with AI-powered discovery and continuing through biosynthesis, biomanufacturing, downstream processing, and finished formulations. The company utilizes its BeautyORB platform to computationally screen vast chemical libraries and predict novel bioactives, which then proceed through validation, safety testing, and formulation for skincare and haircare applications. Debut employs both engineered microbial fermentation and cell-free enzymatic systems to produce these novel ingredients sustainably and then transitions them into proprietary formulations or custom white-label products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $86.2M
- Last round: Series Unknown (Aug 2025)
- Website: debutbiotech.com
- Phone: [email protected]
Industries & Categories
Beauty, Biotechnology, Consumer Goods, Cosmetics, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/debut-123479 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.